FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Epistemonikos ID: c13d06a0bade704be21d2174cb8b24bd1aa0a17b
First added on: May 12, 2024